Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Trostberg, April 3, 2019 – Ulli Seibel, CEO of AlzChem Group AG, informed the Supervisory Board today that he will no longer be available to the company for personal reasons after the expiration of his contract, which runs until December 31, 2019.
The Supervisory Board notes with regret Mr. Seibel's decision not to extend his contract after ten years on the Management Board and thanks him for his work. The necessary steps to fill the Management Board mandate from 2020 will be taken soon.